ABO Blood Type Incompatibility Is Not a Risk Factor of Outcomes for Acute Myeloid Leukemia (AML) Patients After Unmanipulated Haplo-identical Peripheral Blood Hematopoietic Stem Cell Transplantation

Nan Yang(Capital Medical University), Chunji Gao(Chinese PLA General Hospital), Zhe Gao(Hebei Medical University), Lan Luo(Chinese People's Liberation Army), Feiyan Wang(Chinese General Hospital College of Nursing and Liberal Arts), Shu Fang(Peking University), Chengying Zhu(Chinese People's Liberation Army), Lixun Guan(Chinese General Hospital College of Nursing and Liberal Arts), Zhanxiang Liu(Tianjin University), Zhenyang Gu(Chinese General Hospital College of Nursing and Liberal Arts), Yi Ding(Sichuan University)
Annals of Transplantation
June 14, 2019
Cited by 2


Related Papers